- Home
- GBLI vs QSI Comparison
GBLI vs QSI Comparison
Compare GBLI & QSI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GBLI
- QSI
- Stock Information
- Founded
- GBLI 2016
- QSI 2013
- Country
- GBLI United States
- QSI United States
- Employees
- GBLI N/A
- QSI N/A
- Industry
- GBLI Property-Casualty Insurers
- QSI Biotechnology: Pharmaceutical Preparations
- Sector
- GBLI Finance
- QSI Health Care
- Exchange
- GBLI Nasdaq
- QSI Nasdaq
- Market Cap
- GBLI 421.5M
- QSI 208.6M
- IPO Year
- GBLI 2003
- QSI N/A
- Fundamental
- Price
- GBLI $29.68
- QSI $1.12
- Analyst Decision
- GBLI
- QSI Strong Buy
- Analyst Count
- GBLI 0
- QSI 3
- Target Price
- GBLI N/A
- QSI $2.38
- AVG Volume (30 Days)
- GBLI 6.0K
- QSI 6.7M
- Earning Date
- GBLI 08-06-2025
- QSI 08-05-2025
- Dividend Yield
- GBLI 4.72%
- QSI N/A
- EPS Growth
- GBLI N/A
- QSI N/A
- EPS
- GBLI 1.98
- QSI N/A
- Revenue
- GBLI $439,280,000.00
- QSI $3,412,000.00
- Revenue This Year
- GBLI $5.48
- QSI $45.62
- Revenue Next Year
- GBLI $7.91
- QSI $218.03
- P/E Ratio
- GBLI $14.96
- QSI N/A
- Revenue Growth
- GBLI N/A
- QSI 100.47
- 52 Week Low
- GBLI $26.94
- QSI $0.61
- 52 Week High
- GBLI $37.00
- QSI $5.77
- Technical
- Relative Strength Index (RSI)
- GBLI 50.21
- QSI 34.78
- Support Level
- GBLI $29.15
- QSI $0.95
- Resistance Level
- GBLI $29.90
- QSI $1.14
- Average True Range (ATR)
- GBLI 0.72
- QSI 0.08
- MACD
- GBLI 0.14
- QSI 0.02
- Stochastic Oscillator
- GBLI 69.29
- QSI 62.96
About GBLI Global Indemnity Group LLC (DE)
Global Indemnity Group LLC provides both admitted and non-admitted specialty property and casualty insurance coverages and individual policyholder coverages in the United States, as well as reinsurance world-wide. The company's two segments are: Penn-America and Non-Core Operations. The Penn-America segment offers specialty property and casualty products designed for its Wholesale Commercial, Specialty Products, InsurTech, and Assumed Reinsurance product offerings. These product lines are offered in the excess and surplus lines marketplace; and Non-Core Operations segment contains lines of business that have been de-emphasized or are no longer being written. The majority of its revenue is from the the Penn-America segment . Geographically, the majority is from California.
About QSI Quantum-Si Incorporated
Quantum-Si Inc is a life sciences company focused on the development and commercialization of proteomics research tools. The company has designed and developed a hardware, consumable, and software solution to provide a solution for protein detection and analysis. It has developed a proprietary universal single-molecule detection platform that enables Next-Generation Protein Sequencing (NGPS), the ability to sequence proteins.